Clinical trials for first-ever human hookworm vaccine advance
The Sabin Vaccine Institute (Sabin) today announced the start of Part II of its Phase I clinical trial of the Na-GST-1 vaccine candidate, marking another major milestone in the progress toward developing a human hookworm ...
Nov 5, 2012
0
0